Live feed16:24:33·739dINSIDERFilingvia QuantisnowChief Financial Officer Ogden Christopher was granted 17,500 shares, increasing direct ownership by 20% to 103,186 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CTMX· CytomX Therapeutics Inc.Health CareOriginal source
